IVIEW Therapeutics
Business Services · New Jersey, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
5 Cedarbrook Dr Ste 2, Cranbury, New Jer...Phone Number
(267) 370-5425Website
www.iviewtherapeutics.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About IVIEW Therapeutics
iVIEW Therapeutics Inc. is a clinical stage ophthalmology drug development company. Its lead compound iVIEW-1201 is starting global phase II human clinical trials in early 2019 for the treatment of viral conjunctivitis, which is an unmet medical need with no current FDA approved treatment. iVIEW was established by serial entrepreneurs and clinical physicians and funded by reputable VCs and strategic corporate investors. Headquartered in Pennsylvania Biotechnology Center in Doylestown, with over 1000 sq. ft. laboratories and offices. China headquarter is located in Hengqin New District, Zhuhai City with a development/manufacturing base located in Wuhu City, Anhui Province. The company is building a solid product pipeline with both clinical and pre-clinical assets through both in-house innovation research and global product in-licensing. The company's novel drug development strategy centered in:Explore more
IVIEW Therapeutics Org Chart
JZ
Senior Scientist & Research Scientist
YP
Senior Scientist
PP
Research & Development Associate Scientist
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is IVIEW Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
IVIEW Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when IVIEW Therapeutics launches new products
Check if IVIEW Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Check out if IVIEW Therapeutics is spiking on competitors!
Funding: Get notified immidiatlly once IVIEW Therapeutics has new funding data
Earning: See what the market has to say on IVIEW Therapeutics recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if IVIEW Therapeutics had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at IVIEW Therapeutics
Recommended Actions
Find VP level buyers at IVIEW Therapeutics
Find 3 more new buyers
Compare Similar Companies to IVIEW Therapeutics
Compare insights from companies similar to IVIEW Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
IVIEW Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
IVIEW Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about IVIEW Therapeutics.
IVIEW Therapeutics Tech Stack
A closer look at the technologies used by IVIEW Therapeutics
See more technologies
Most Recent Scoops
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
Laboratory Operations, Medical Research, Clinical Operations
Partnership
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
Product Development, Research & Development, Medical Research, Pharmaceuticals, Clinical Operations
Project
Product Development, Media / Creative Agency, Pharmaceuticals, Clinical Operations
IVIEW Therapeutics News & Media
IVIEW Therapeutics Inc. Completes Patient Recruitment for Phase 1/2 Trial of IVW-1001 Ophthalmic Eyelid Wipe in Dry Eye Disease Patients
CRANBURY, N.J., Sept. 17, 2024 /PRNewswire/ -- IVIEW Therapeutics Inc., a clinical-stage biotechnology company dedicated to advancing innovative treatments for ocular diseases, today announced the completion of patient recruitment for its Phase 1/2 clinical trial evaluating IVW-1001, a...iView Therapeutics Inc. Announced FDA’s Clearance of IND Application for IVW-1001 Ophthalmic Eyelid Wipe to Treat Signs and Symptoms of Dry Eye Disease
iView Therapeutics Inc., a clinical stage biotechnology company dedicated to advancing innovative treatments for ocular diseases, announces that the U.S. Food and Drug Administration (FDA) cleared iView’s Investigational New Drug (IND) application to for the initiation of a Phase 1/2 clinical trial as safe to proceed. The trial will evaluate the Safety, Tolerability, and Efficacy of IVW-1001, a novel TRPM8 agonist, [PR.com]IVIEW Announces Presentation of Positive Topline Results in Phase II Clinical Study of IVIEW-1201 for the Treatment of Bacterial Conjunctivitis at ARVO 2024
IVIEW Therapeutics Inc. announces to present the positive topline result in the Phase II Clinical Study of IVIEW-1201 for the Treatment of Bacterial Conjunctivitis in the upcoming 2024 ARVO (The Association for Research in Vision and Ophthalmology) national meeting in Seattle, WA. The Presentation is scheduled as an oral presentation at 9:15am on May 7, 2024. The presentation will report topline data on a recently [PR.com]IVIEW Collaboration With Dr. Amin Javer at St. Paul's Hospital and Sinus Centre, Canada to Study Povidone Iodine Formulations Including IVIEW-1503, a Long-Lasting Povidone Iodine Nasal Spray for the Treatment of COVID-19
IVIEW Therapeutics Inc., an innovative clinical-stage specialty pharmaceutical company, is proud to announce that Health Canada has offered Dr. A ...
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding IVIEW Therapeutics
Sign Up For FreeTo access detailed company insights
iVIEW Therapeutics Inc. is a clinical stage ophthalmology drug development company. Its lead compound iVIEW-1201 is starting global phase II human clinical trials in early 2019 for the treatment of viral conjunctivitis, which is an unmet medical need with no current FDA approved treatment. iVIEW was established by serial entrepreneurs and clinical... Read More
